<p>Mouse CD8<sup>+</sup> T cells were nucleofected with <i>cblb</i> siRNA or control siRNA and stimulated with anti-CD3 and anti-CD28 in the presence or absence of TGFβ. The production of IFNγ by CD8<sup>+</sup> T cells was efficiently suppressed by exposure to TGFβ while <i>cblb</i> knockdown cells still produced high levels of IFNγ. (A) Silencing efficacy of <i>cblb</i> siRNA was analyzed by immunoblotting. (B) Supernatants were taken two days post-transfection and the amount of IFNγ secreted was measured by BioPlex technology. IFNγ levels of each group without TGFβ were set 100%. Means ± SEM of three independent experiments are shown.</p
<p>Untouched purified CD4<sup>+</sup> T cells (5×10<sup>4</sup> cells/well) and CD8<sup>+</sup> T ce...
<p>(A) Analysis of intact OT-I and OT-I/DNRII mice. Spleen and lymph node cells from OT-I/DNRII mice...
<p>B16ova tumor bearing mice were treated twice with SIINFEKL-pulsed DCs plus CD8<i><sup>+</sup></i>...
<p>Human CD8<sup>+</sup> T cells were nucleofected with <i>CBLB</i> siRNA #10 or control siRNA and s...
<p>Tumor infiltrating CD8<sup>+</sup> T cells either nucleofected with control siRNA or <i>cblb</i> ...
The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We rece...
The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We rece...
<p>(A) Intracellular cytokine expression by CD8<sup>+</sup> T cells was analyzed using a flow cytome...
<p>Flow cytometric analysis of tumor-infiltrating lymphocytes 7 days (A, B, D, E) or 4 days (C) afte...
<p>(A) Tumor therapy schedule. Wild type mice s.c. injected with 1×10<sup>5</sup> B16ova cells were ...
<p>Cells isolated from the spleens and lymph nodes of regular NOD mice (A,B); BDC2.5 TCR transgenic ...
<p>Total CD4<sup>+</sup> T cells were stimulated with anti-CD3/CD28 antibodies for four days in the ...
<p>(A, B) IL-18 production from DCs. (A) DCs isolated from spleen of IFN-γR1<sup>−/−</sup> and wild ...
<p>Mice were immunized by IM-EP with 50 µg of E7 DNA vaccines (pE7) at 0 and 1 weeks. At 2 weeks, th...
<p>Mice were inoculated with Sarcoma 180 cells (1×10<sup>6</sup> cells/mice) and after the formation...
<p>Untouched purified CD4<sup>+</sup> T cells (5×10<sup>4</sup> cells/well) and CD8<sup>+</sup> T ce...
<p>(A) Analysis of intact OT-I and OT-I/DNRII mice. Spleen and lymph node cells from OT-I/DNRII mice...
<p>B16ova tumor bearing mice were treated twice with SIINFEKL-pulsed DCs plus CD8<i><sup>+</sup></i>...
<p>Human CD8<sup>+</sup> T cells were nucleofected with <i>CBLB</i> siRNA #10 or control siRNA and s...
<p>Tumor infiltrating CD8<sup>+</sup> T cells either nucleofected with control siRNA or <i>cblb</i> ...
The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We rece...
The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We rece...
<p>(A) Intracellular cytokine expression by CD8<sup>+</sup> T cells was analyzed using a flow cytome...
<p>Flow cytometric analysis of tumor-infiltrating lymphocytes 7 days (A, B, D, E) or 4 days (C) afte...
<p>(A) Tumor therapy schedule. Wild type mice s.c. injected with 1×10<sup>5</sup> B16ova cells were ...
<p>Cells isolated from the spleens and lymph nodes of regular NOD mice (A,B); BDC2.5 TCR transgenic ...
<p>Total CD4<sup>+</sup> T cells were stimulated with anti-CD3/CD28 antibodies for four days in the ...
<p>(A, B) IL-18 production from DCs. (A) DCs isolated from spleen of IFN-γR1<sup>−/−</sup> and wild ...
<p>Mice were immunized by IM-EP with 50 µg of E7 DNA vaccines (pE7) at 0 and 1 weeks. At 2 weeks, th...
<p>Mice were inoculated with Sarcoma 180 cells (1×10<sup>6</sup> cells/mice) and after the formation...
<p>Untouched purified CD4<sup>+</sup> T cells (5×10<sup>4</sup> cells/well) and CD8<sup>+</sup> T ce...
<p>(A) Analysis of intact OT-I and OT-I/DNRII mice. Spleen and lymph node cells from OT-I/DNRII mice...
<p>B16ova tumor bearing mice were treated twice with SIINFEKL-pulsed DCs plus CD8<i><sup>+</sup></i>...